logo
#

Latest news with #addictiontreatment

Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
Navamedic ASA: Closing of the transaction to acquire the business of dne pharma

Yahoo

time15-07-2025

  • Business
  • Yahoo

Navamedic ASA: Closing of the transaction to acquire the business of dne pharma

OSLO, Norway, July 15, 2025 /PRNewswire/ -- Reference is made to the stock exchange announcement published by Navamedic ASA ("Navamedic" or the "Company", OSE ticker: "NAVA") on 23 June 2025, regarding Navamedic entering into an asset purchase agreement for the acquisition of the business of dne pharma AS for a total consideration of up to NOK 225 million, whereby NOK 185 million is payable at closing, and the remaining NOK 40 million is payable in two tranches subject to achievement of certain agreed sales volumes for the acquired products (the "Transaction"). Navamedic is pleased to announce that the Transaction has today been successfully completed. The Acquisition encompasses dne pharma's business, including product portfolio, key employees and all essential contracts of the business, intellectual property, licenses, and distribution agreements. The product portfolio includes prominent products such as Ventizolve® (intranasal naloxone spray for opioid overdose reversal), Levopidon® (levomethadone), and Metadon Dne (methadone) for opioid substitution therapy. The acquired business will be integrated into Navamedic's existing commercial platform, enabling rapid market access and geographic expansion across the Nordics and selected European markets. "This acquisition represents a significant step in our strategic expansion into the rapidly growing field of addiction treatment and is well aligned with our long-term growth ambitions. Thanks to the strong collaboration among all parties involved, the transaction was completed in a smooth and efficient manner. We are pleased that the General Meeting unanimously approved the Rights Issue yesterday, and we are sincerely grateful for the continued support of Kistefos and the other underwriters," said Kathrine Gamborg Andreassen, CEO of Navamedic. The Acquisition is financed through a combination of new debt in the amount of NOK 110 million from Nordea Bank Abp, filial i Norge ("Nordea") and a rights issue approved at an extraordinary general meeting of Navamedic on 14 July (the "Rights Issue"). Navamedic has been assisted by DNB Carnegie a part of DNB Bank ASA ("DNB Carnegie") and Advokatfirmaet Thommessen ("Thommessen") in connection with the Acquisition, and Navamedic has been granted a bridge loan from Nordea enabling completion of the Acquisition before completion of the Rights Issue. Navamedic has retained DNB Carnegie, and Nordea Corporate Finance, a part of Nordea Bank Abp, filial i Norge as managers and Thommessen as legal advisors for the Rights Issue. "We are very pleased closing this transaction with Navamedic and we are confident that the Navamedic team will continue to grow the opioid substitution business developed by dne pharma, in particular the Ventizolve® products," says Geir Ove Engeset, CEO of dne pharma as. For further information, please contact: Lars Hjarrand, CFO, Mobile: +47 917 62 842 E-mail: orKathrine Gamborg Andreassen, CEO, Mobile: +47 951 78 880 E-mail: kathrine@ About Navamedic Navamedic ASA is a Nordic pharmaceutical company dedicated to enhancing people's quality of life by being a reliable supplier of high-quality prescription, consumer health, and hospital products to hospitals and pharmacies. Our growing product portfolio has been carefully selected to meet current public health concerns, such as obesity, Parkinson's disease, and gastro-related ailments, to empower people to live healthier and more fulfilling lives. What sets us apart is our deep-rooted commitment to understanding the needs and requirements of the countries where we are present. Our local insight and competence enable us to understand the specific needs of each country where we operate and ultimately to gain market access. This makes us a preferred partner for international companies expanding their footprint across the Nordics and Benelux regions, through either in-licensing or out-licensing. Navamedic has been listed on the Oslo Stock Exchange since 2006 (ticker: NAVA) and is headquartered in Oslo, Norway. For more information, please visit About dne pharma/Pharma Production Prior to closing of the Transaction, dne pharma was a Norwegian developer and distributor of addiction and pain therapies, including opioid substitution treatments and emergency overdose medications. dne pharma's wholly owned subsidiary, Pharma Production AS, will continue to manufacture and supply the product portfolio recently acquired by Navamedic, as well as concentrate on contract manufacturing and development services, including analytical services, supporting the long-term need for national pharmaceutical production capacity. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This information was brought to you by Cision View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

In a nation growing hostile toward drugs and homelessness, Los Angeles tries harm reduction
In a nation growing hostile toward drugs and homelessness, Los Angeles tries harm reduction

CBS News

time07-07-2025

  • Health
  • CBS News

In a nation growing hostile toward drugs and homelessness, Los Angeles tries harm reduction

Los Angeles — Inside a bright new building in the heart of Skid Row, homeless people hung out in a canopy-covered courtyard — some waiting to take a shower, do laundry, or get medication for addiction treatment. Others relaxed on shaded grass and charged their phones as an intake line for housing grew more crowded. The Skid Row Care Campus officially opened this spring with ample offerings for people living on the streets of this historically downtrodden neighborhood. Pop-up fruit stands and tent encampments lined the sidewalks, as well as dealers peddling meth and fentanyl in open-air drug markets. Some people, sick or strung out, were passed out on sidewalks as pedestrians strolled by on a recent afternoon. For those working toward sobriety, clinicians are on site to offer mental health and addiction treatment. Skid Row's first methadone clinic is set to open here this year. For those not ready to quit drugs or alcohol, the campus provides clean syringes to more safely shoot up, glass pipes for smoking drugs, naloxone to prevent overdoses, and drug test strips to detect fentanyl contamination, among other supplies. As many Americans have grown increasingly intolerant of street homelessness, cities and states have returned to tough-on-crime approaches that penalize people for living outside and for substance use disorders. But the Skid Row facility shows Los Angeles County leaders' embrace of the principle of harm reduction, a range of more lenient strategies that can include helping people more safely use drugs, as they contend with a homeless population estimated around 75,000 — among the largest of any county in the nation. Evidence shows the approach can help individuals enter treatment, gain sobriety, and end their homelessness, while addiction experts and county health officials note it has the added benefit of improving public health. "We get a really bad rap for this, but this is the safest way to use drugs," said Darren Willett, director of the Center for Harm Reduction on the new Skid Row Care Campus. "It's an overdose prevention strategy, and it prevents the spread of infectious disease." The new Skid Row Care Campus offers homeless people health care and a place to rest, charge their phones, grab some food, or even get connected with housing. Angela Hart / KFF Health News Despite a decline in overdose deaths, drug and alcohol use continues to be the leading cause of death among homeless people in the county. Living on the streets or in sordid encampments, homeless people saddle the health care system with high costs from uncompensated care, emergency room trips, inpatient hospitalizations, and, for many of them, their deaths. Harm reduction, its advocates say, allows homeless people the opportunity to obtain jobs, taxpayer-subsidized housing, health care, and other social services without being forced to give up drugs. Yet it's hotly debated. Politicians around the country, including Gov. Gavin Newsom in California, are reluctant to adopt harm reduction techniques, such as needle exchanges or supervised places to use drugs, in part because they can be seen by the public as condoning illicit behavior. Although Democrats are more supportive than Republicans, a national poll this year found lukewarm support across the political spectrum for such interventions. Los Angeles is defying President Trump's agenda as he advocates for forced mental health and addiction treatment for homeless people — and locking up those who refuse. The city has also been the scene of large protests against Mr. Trump's immigration crackdown, which the president has fought by deploying National Guard troops and Marines. Mr. Trump's most detailed remarks on homelessness and substance use disorder came during his campaign, when he attacked people who use drugs as criminals and said that homeless people "have no right to turn every park and sidewalk into a place for them to squat and do drugs." Health and Human Services Secretary Robert F. Kennedy Jr. reinforced Mr. Trump's focus on treatment. "Secretary Kennedy stands with President Trump in prioritizing recovery-focused solutions to address addiction and homelessness," said agency spokesperson Vianca Rodriguez Feliciano. "HHS remains focused on helping individuals recover, communities heal, and help make our cities clean, safe, and healthy once again." A comprehensive report led by Margot Kushel, a professor of medicine at the University of California-San Francisco, this year found that nearly half of California's homeless population had a complex behavioral health need, defined as regular drug use, heavy drinking, hallucinations, or a recent psychiatric hospitalization. The chaos of living outside, she said — marked by violence, sexual assault, sleeplessness, and lack of housing and health care — can make it nearly impossible to get sober. Skid Row Care Campus The new care campus is funded by about $26 million a year in local, state, and federal homelessness and health care money, and initial construction was completed by a Skid Row landlord, Matt Lee, who made site improvements on his own, according to Anna Gorman, chief operating officer for community programs at the Los Angeles County Department of Health Services. Operators say the campus should be able to withstand potential federal spending cuts because it is funded through a variety of sources. Glass front doors lead to an atrium inside the yellow-and-orange complex. It was designed with input from homeless people, who advised the county not just on the layout but also on the services offered on-site. There are 22 recovery beds and 48 additional beds for mostly older homeless people, arts and wellness programs, a food pantry, and pet care. Even bunnies and snakes are allowed. John Wright, 65, who goes by the nickname Slim, mingled with homeless visitors one afternoon in May, asking them what they needed to be safe and comfortable. "Everyone thinks we're criminals, like we're out robbing everyone, but we aren't," said Wright, who is employed as a harm reduction specialist on the campus and is trying, at his own pace, to stop using fentanyl. "I'm homeless and I'm a drug addict, but I'm on methadone now so I'm working on it," he said. Nearby on Skid Row, Anthony Willis rested in his wheelchair while taking a toke from a crack pipe. He'd just learned about the new care campus, he said, explaining that he was homeless for roughly 20 years before getting into a taxpayer-subsidized apartment on Skid Row. He spends most of his days and nights on the streets, using drugs and alcohol. The drugs, he said, help him stay awake so he can provide companionship and sometimes physical protection for homeless friends who don't have housing. "It's tough sometimes living down here; it's pretty much why I keep relapsing," said Willis, who at age 62 has asthma and arthritic knees. "But it's also my community." Willis said the care campus could be a place to help him kick drugs, but he wasn't sure he was ready. Research shows harm reduction helps prevent death and can build long-term recovery for people who use substances, said Brian Hurley, an addiction psychiatrist and the medical director for the Bureau of Substance Abuse Prevention and Control at the Los Angeles County Department of Public Health. The techniques allow health care providers and social service workers to meet people when they're ready to stop using drugs or enter treatment. "Recovery is a learning activity, and the reality is relapse is part of recovery," he said. "People go back and forth and sometimes get triggered or haven't figured out how to cope with a stressor." Swaying public opinion Under harm reduction principles, officials acknowledge that people will use drugs. Funded by taxpayers, the government provides services to use safely, rather than forcing people to quit or requiring abstinence in exchange for government-subsidized housing and treatment programs. Los Angeles County is spending hundreds of millions to combat homelessness, while also launching a multiyear "By LA for LA" campaign to build public support, fight stigma, and encourage people to use services and seek treatment. Officials have hired a nonprofit, Vital Strategies, to conduct the campaign including social media advertising and billboards to promote the expansion of both treatment and harm reduction services for people who use drugs. The organization led a national harm reduction campaign and is working on overdose prevention and public health campaigns in seven states using roughly $70 million donated by Michael Bloomberg, the former mayor of New York. "We don't believe people should die just because they use drugs, so we're going to provide support any way that we can," said Shoshanna Scholar, director of harm reduction at the Los Angeles County Department of Health Services. "Eventually, some people may come in for treatment but what we really want is to prevent overdose and save lives." Los Angeles also finds itself at odds with California's Democratic governor. Newsom has spearheaded stricter laws targeting homelessness and addiction and has backed treatment requirements for people with mental illness or who use drugs. Last year, California voters approved Proposition 36, which allows felony charges for some drug crimes, requires courts to warn people they could be charged with murder for selling or providing illegal drugs that kill someone, and makes it easier to order treatment for people who use drugs. Even San Francisco approved a measure last year that requires welfare recipients to participate in treatment to continue receiving cash aid. Mayor Daniel Lurie recently ordered city officials to stop handing out free drug supplies, including pipes and foil, and instead to require participation in drug treatment to receive services. Lurie signed a recovery-first ordinance, which prioritizes "long-term remission" from substance use, and the city is also expanding policing while funding new sober-living sites and treatment centers for people recovering from addiction. "Harm encouragement" State Sen. Roger Niello, a Republican who represents conservative suburbs outside Sacramento, says the state needs to improve the lives of homeless people through stricter drug policies. He argues that providing drug supplies or offering housing without a mandate to enter treatment enables homeless people to remain on the streets. Proposition 36, he said, needs to be implemented forcefully, and homeless people should be required to enter treatment in exchange for housing. "I think of it as tough love," Niello said. "What Los Angeles is doing, I would call it harm encouragement. They're encouraging harm by continuing to feed a habit that is, quite frankly, killing people." Keith Humphreys, who worked in the George W. Bush and Barack Obama administrations and pioneered harm reduction practices across the nation, said that communities should find a balance between leniency and law enforcement. "Parents need to be able to walk their kids to the park without being traumatized. You should be able to own a business without being robbed," he said. "Harm reduction and treatment both have a place, and we also need prevention and a focus on public safety." Just outside the Skid Row Care Campus, Cindy Ashley organized her belongings in a cart after recently leaving a local hospital ER for a deep skin infection on her hand and arm caused by shooting heroin. She also regularly smokes crack, she said. She was frantically searching for a home so she could heal from two surgeries for the infection. She learned about the new care campus and rushed over to get her name on the waiting list for housing. "I'm not going to make it out here," she said, in tears. KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

Ibogaine by David Dardashti Takes Center Stage on Day One of Psychedelic Science Conference 2025, Emphasizing Collaboration, Education, and Industry Synergy
Ibogaine by David Dardashti Takes Center Stage on Day One of Psychedelic Science Conference 2025, Emphasizing Collaboration, Education, and Industry Synergy

Globe and Mail

time19-06-2025

  • Health
  • Globe and Mail

Ibogaine by David Dardashti Takes Center Stage on Day One of Psychedelic Science Conference 2025, Emphasizing Collaboration, Education, and Industry Synergy

DENVER, CO - June 19, 2025 - Ibogaine by David Dardashti, a leading initiative in ibogaine research and advocacy, today commenced its participation in the highly anticipated Psychedelic Science Conference 2025 in Denver, Colorado. As the conference officially began its main programming today, June 18th, the presence of Ibogaine by David Dardashti marks a pivotal moment for the burgeoning field of psychedelic medicine, championing a collaborative approach to advance ibogaine's therapeutic potential, particularly in the realm of addiction treatment. On this crucial first day of the conference, which runs from June 16-20, 2025 (with workshops on June 16th and 17th preceding the main conference), representatives of Ibogaine by David Dardashti are engaging with a diverse array of stakeholders, focusing on three key areas: potential collaborations with integration-based psychedelic therapies, offering internship opportunities to students of psychedelic studies, fostering synergy with other industries for enhanced news exposure within the psychedelic sub-sector. "The future of psychedelic medicine, especially ibogaine, lies in our collective ability to integrate these powerful experiences into comprehensive, supportive care models," stated David Dardashti, the driving force behind Ibogaine by David Dardashti. "Our discussions here at Psychedelic Science 2025 are centered on forging partnerships with organizations dedicated to integration-based therapies. It's not enough to simply administer a compound; we must ensure individuals receive the robust psychological and spiritual support necessary to process and implement the profound insights gained from their ibogaine journeys." Recognizing the critical need for a skilled workforce in this evolving field, Ibogaine by David Dardashti is also actively promoting internship opportunities for students pursuing psychedelic studies. "The next generation of researchers, therapists, and advocates will be instrumental in shaping the trajectory of psychedelic medicine," Dardashti emphasized. "We are committed to providing hands-on experience and mentorship to talented students, empowering them to contribute meaningfully to this vital area of healthcare." These internships aim to bridge the gap between academic learning and practical application, offering students invaluable exposure to clinical research, patient care, and policy development related to ibogaine. Furthermore, Ibogaine by David Dardashti is keen to expand the reach and understanding of ibogaine within the broader public discourse. The initiative is exploring collaborations with media and other industries to facilitate greater news exposure for the psychedelic sub-sector. "Accurate and responsible media representation is paramount to dispelling misconceptions and fostering public acceptance of psychedelics as legitimate therapeutic tools," Dardashti noted. "By partnering with key industry players, we can ensure that the scientific advancements and profound patient stories surrounding ibogaine receive the attention they deserve, moving beyond sensationalism to substantive reporting." The engagements of Ibogaine by David Dardashti at Psychedelic Science 2025, particularly on this opening day of the main conference, underscore its commitment to fostering a holistic and collaborative ecosystem for ibogaine's integration into mainstream medicine. The initiative's vision extends beyond singular research efforts, encompassing a comprehensive strategy for patient support, professional development, and public education, all crucial elements for the responsible and effective rollout of psychedelic-assisted therapies. About Ibogaine by David Dardashti: Ibogaine by David Dardashti is a renowned initiative led by David Dardashti, dedicated to exploring ibogaine's potential in treating addiction and other mental health challenges. With a deep commitment to ethical practices and patient well-being, the initiative champions a holistic approach to psychedelic therapy, emphasizing the importance of integration and ongoing support.

The Recovery Team-Cape Cod Addiction Treatment Center Launches Mental Health Program Amid Growing Mental Health Crisis
The Recovery Team-Cape Cod Addiction Treatment Center Launches Mental Health Program Amid Growing Mental Health Crisis

Associated Press

time16-06-2025

  • Health
  • Associated Press

The Recovery Team-Cape Cod Addiction Treatment Center Launches Mental Health Program Amid Growing Mental Health Crisis

Falmouth addiction treatment facility adds a dedicated mental health program to ease the mental health crisis. 'When we combine mental health care with holistic services, patients stabilize faster and achieve better outcomes.'— Dr. Sal Raichbach, chief clinical officer at The Recovery Team - Cape Cod FALMOUTH, MA, UNITED STATES, June 16, 2025 / / -- The Recovery Team - Cape Cod is expanding its addiction treatment program, adding a separate program for mental health patients. This means people can access high-quality, comprehensive mental health care even if they don't have a substance use disorder. The expansion makes critical mental health services more accessible at a time when they're needed the most. According to the National Institute of Mental Health, more than one in five adults—23.1 percent—now experience a mental illness, a rate that has climbed steadily from 17.7 percent in 2008. At The Recovery Team - Cape Cod, patients with mental health conditions now have access to multiple levels of care, including full-day, partial-day treatment programs and a virtual evening program. Previously, those levels of care were reserved for substance use disorder and dual diagnosis patients. The Recovery Team - Cape Cod, formerly Recovering Champions, is one of the few programs in the region licensed to treat both substance use and primary mental health conditions. 'We've seen how untreated mental health conditions can disrupt recovery and increase the risk of hospitalization,' Dr. Sal Raichbach, The Recovery Team's chief clinical officer, said. 'When we combine mental health care with holistic services, patients stabilize faster and achieve better outcomes.' Setting a New Standard in Mental Health Care The facility takes a comprehensive, whole-person approach to treatment. Patients–whether recovering from mental health, substance use, or both–have access to a combination of evidence-based therapies like cognitive behavioral therapy, dialectical behavioral therapy and trauma-focused work with holistic modalities such as yoga, acupuncture, massage, Reiki, art and music therapy. Beyond therapy, the program is designed to support emotional and physical well-being. Patients benefit from outings unique to Cape Cod, such as fly fishing. They learn to tie flies and land catches, which builds focus, confidence and relieves stress. Patients fly fish, learning to cast for striped bass and bluefish. Every activity ties back to a whole-person approach, strengthening mental and physical health. Support for Long-Term Recovery Clients receive help with life logistics, such as completing Family and Medical Leave Act (FMLA) paperwork and other legal forms. Recovery doesn't stop at discharge. Graduates join an alumni program that provides long-term peer support, care coordination and ongoing recovery resources. Robert Souza is a Recovery Team - Cape Cod alum. He received treatment for PTSD and substance use disorder. Souza celebrates two years of continuous sobriety on June 26. 'If I didn't go, I don't think I would be here today. My life is great today!' Souza said. 'Recovery isn't just about getting through the day. It's about finding purpose, support and a path forward,' Dr. Raichbach said. 'That's what we offer here on Cape Cod. It's not only treatment but also long-term recovery.' About The Recovery Team - Cape Cod The Recovery Team – Cape Cod, a division of Haven Health Management, is dedicated to expanding access to mental health and substance use care in Massachusetts. The facility specializes in full-day treatment, partial-day treatment programs and alumni services that provide recovery resources long after treatment ends. The organization is accredited by the Joint Commission and licensed by the Massachusetts Department of Public Health and the Massachusetts Bureau of Substance Abuse. The Recovery Team - Cape Cod is located at 279 Brick Kiln Road, East Falmouth, MA 02536. Marianly Hernández Primmer The Recovery Team - Cape Cod +1 954-774-2287 email us here Visit us on social media: LinkedIn Instagram Facebook Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Asana Recovery Responds to Increased Demand for Outpatient Addiction Treatment in Orange County
Asana Recovery Responds to Increased Demand for Outpatient Addiction Treatment in Orange County

Associated Press

time13-06-2025

  • Health
  • Associated Press

Asana Recovery Responds to Increased Demand for Outpatient Addiction Treatment in Orange County

Outpatient addiction treatment in Orange County is surging as patients prioritize flexibility, privacy, and personalized care. 'Outpatient care allows us to meet clients where they are—offering effective treatment without interrupting their lives.'— Mark Shandrow, CEO of Asana Recovery ORANGE COUNTY, CA, UNITED STATES, June 13, 2025 / / -- Addiction treatment providers in Orange County are observing a noticeable shift toward outpatient drug rehab programs as more individuals seek flexible recovery options that allow them to continue participating in their daily lives. In response, Asana Recovery, a behavioral health provider based in Costa Mesa, has expanded its outpatient services to meet this growing demand. Asana Recovery now offers a range of outpatient programs designed to support individuals with substance use disorders and co-occurring mental health conditions. These services include standard outpatient treatment, an Intensive Outpatient Program (IOP), and access to virtual care, allowing for greater flexibility without compromising clinical effectiveness. Outpatient Drug Rehab: A Growing Trend in Orange County Outpatient rehab programs provide an alternative to inpatient treatment by enabling participants to receive structured care while continuing to live at home. This format allows clients to maintain work, school, and family obligations, which is increasingly important for adults balancing multiple responsibilities. 'Outpatient care is an important part of the recovery continuum,' said a spokesperson for Asana Recovery. 'It offers stability, accessibility, and the opportunity for clients to remain engaged in their everyday environment while receiving professional support.' Many individuals in Orange County are choosing outpatient care due to its adaptability, lower cost compared to inpatient programs, and its capacity to preserve privacy and minimize disruption to daily routines. Expanded Outpatient Services at Asana Recovery Asana Recovery's outpatient programs are personalized based on each client's clinical and lifestyle needs. The multidisciplinary team provides: • Individual Therapy: One-on-one sessions focused on identifying triggers, developing coping strategies, and addressing past trauma. • Group Therapy: Facilitated peer groups that encourage accountability and shared learning experiences. • Medication Management: Oversight for clients prescribed medications to support recovery or manage co-occurring conditions. • Life Skills Support: Resources for managing stress, building healthy routines, and reintegrating into work or school environments. For individuals requiring a higher level of care, Asana's Intensive Outpatient Program (IOP) offers structured programming several days per week. This option serves as a transitional step for those moving from detox or inpatient care and is also suitable for individuals who need enhanced support but cannot commit to residential treatment. Integrating Mental Health and Addiction Treatment Asana Recovery integrates dual diagnosis treatment into its outpatient programs, recognizing the link between substance use and mental health disorders such as anxiety, depression, and trauma. By addressing both simultaneously, the center aims to improve client outcomes and reduce the likelihood of relapse. Improving Access to Care Through Insurance and Support To ensure accessibility, Asana Recovery works with a broad range of insurance providers, including Aetna, Anthem Blue Cross, Blue Shield, Cigna, UMR, United Healthcare, and TriWest. Their team assists clients with verifying coverage and understanding financial options to help remove barriers to care. Who Benefits from Outpatient Treatment? Outpatient treatment is typically appropriate for individuals with mild to moderate substance use disorders, those transitioning from residential programs, or individuals with stable housing and support systems. Asana Recovery conducts thorough assessments to determine whether outpatient care is the right fit for each client. Contact Information For more information about outpatient addiction treatment in Orange County, visit Asana Recovery's website or contact the admissions team directly. Asana Recovery Phone: (949) 763-3440 Email: [email protected] Website: Mark Shandrow Asana Recovery +1 949-763-3440 email us here Visit us on social media: LinkedIn Instagram Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store